Fueling Growth With Strategic Solutions

pharmaceuticals

A global pandemic has highlighted the world’s reliance on leading pharmaceutical companies and has undeniably brought a host of new expansion opportunities to this industry: new drug developments, more advanced technology, and new globalized markets. Yet, volatile pharma supply pipelines, unpredictable government regulations, and declining R&D efficiency continue to hinder growth for many companies.

To move forward at full force, pharmaceutical and life sciences companies must remain on the cutting edge of their fields and quality tends to be a decision-driving priority. Managing expenses often takes a back seat, and indirect suppliers know this and have seized the opportunity. Fine Tune can help. We work with some of the largest pharma and life sciences companies in the world, and they all have appreciated the value we’ve added for them while they focus on mission-critical priorities. Within one year of partnering with a leading life science company, Fine Tune was able to identify over $500,000 in unnecessary costs and redesign their supplier inventory system to guarantee the cost savings would stick while ensuring adequate supply to keep business running smoothly.

“We were introduced to Fine Tune as they were working with Sigma prior to the corporate merger. That said, my team had never worked with a company like Fine Tune and, to be honest, the value proposition of implementing better supplier agreements, managing those agreements to the ‘letter of the contract’ while only paying when we realize savings results seemed too good to be true. "

Brent Farmer, MRO Sourcing Manager, MilliporeSigma

Smart Solutions Sold Here

Contact Us Now